Related Experiment Video
Updated: Feb 2, 2026
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Lupus Nephritis
Scott E Wenderfer1, Karen W Eldin2
1Pediatric Nephrology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, 1102 Bates Avenue, Suite 245, Houston, TX 77030, USA.
Insights
Childhood-onset systemic lupus erythematosus (SLE) presents unique challenges, often involving more severe disease and kidney complications. While mortality is lower than in adults, long-term damage and relapses remain significant concerns for pediatric patients.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Nephrology
Background:
- Childhood-onset systemic lupus erythematosus (SLE) is defined as SLE with onset before 18 years of age.
- This subset often exhibits a stronger genetic predisposition, extensive multisystemic involvement, and a more aggressive disease trajectory compared to adult-onset SLE.
- Key concerns include a higher risk of nephritis and end-stage kidney disease.
Purpose of the Study:
- To summarize the distinct characteristics and clinical course of childhood-onset SLE.
- To highlight the challenges in managing long-term outcomes, including organ damage and complications.
- To underscore the importance of effective immunosuppressive strategies in pediatric lupus patients.
Main Methods:
- Review of existing literature on childhood-onset SLE.
- Analysis of clinical data pertaining to disease severity, organ involvement, and treatment outcomes.
- Comparative assessment of pediatric versus adult-onset SLE patient populations.
Main Results:
- Childhood-onset SLE is associated with greater genetic influence and more widespread organ system engagement.
- Despite lower short-term mortality rates compared to adult SLE, patients face significant risks of nephritis and irreversible organ damage.
- Cardiovascular issues, infections, and disease relapses, particularly during adolescence and young adulthood, are common.
Conclusions:
- Advances in immunosuppression have improved survival but have not eliminated the risk of cumulative damage in childhood-onset SLE.
- Long-term management requires vigilant monitoring for cardiovascular complications, infections, and disease flares.
- Addressing the unique trajectory of pediatric lupus is crucial for optimizing patient outcomes and quality of life.
Abstract:
Childhood-onset systemic lupus erythematosus (SLE) is a subset of SLE with an onset before 18 years of age. Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease. Five- and 10-year mortality is lower than in adult-onset SLE. Although patient and renal survival have improved with advances in induction and maintenance immunosuppression, accumulation of irreversible damage is common. Cardiovascular and infectious complications are frequent, as are relapses during adolescence and the transition to adulthood.
